Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.

@article{Omachi2015ClinicalIO,
  title={Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.},
  author={Yoshie Omachi and Kimiteru Ito and Kunimasa Arima and Hiroshi Matsuda and Yasuhiro Nakata and Masuhiro Sakata and Noriko Sato and Kazuyuki Nakagome and Nobutaka Motohashi},
  journal={Psychiatry and clinical neurosciences},
  year={2015},
  volume={69 12},
  pages={741-51}
}
AIMS The purpose of this study was to evaluate the clinical impact of addition of [(11)C]Pittsburgh compound-B positron emission tomography ((11)C-PiB PET) on routine clinical diagnosis of Alzheimer's disease (AD) dementia and mild cognitive impairment (MCI), and to assess diagnostic agreement between clinical criteria and research criteria of the National Institute on Aging-Alzheimer's Association. METHODS The diagnosis in 85 patients was made according to clinical criteria. Imaging… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…